SUMMARY

On Saturday, May 25th 2019, the Belgian Hematology Society (BHS) organised the first BHS patient network meeting in Brussels. Patients with lymphoma, chronic and acute leukaemia, myeloma, sickle cell disease and myeloproliferative neoplasms, their family members and friends were all welcome. The goal of this symposium was to discuss the role of patient organisations, summarise the latest advances in treatment of the different haematological malignancies and address the affordability of health care and the role of the government. Professor Rik Schots, head of the clinical haematology department at Brussels University Hospital, introduced the patients to haematology and the work of the BHS.

(BELG J HEMATOL 2019;10(6):255–7)